Correction to: Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stress (Nature Cancer, (2022), 3, 7, (866-884), 10.1038/s43018-022-00389-8)

Correction to: Nature Cancerhttps://doi.org/10.1038/s43018-022-00389-8, published online 2 June 2022 In the version of this article initially published, in the legend to Extended Data Fig. 2a, the dose of ERX-41 was reported as 10 mg/kg/day for both BALB/c and nude mice, but the BALB/c mice were in fact administered 20 mg/kg/day. The correct figure legend for Extended Data Fig. 2a is “Nude mice with MDA-MB-231 xenograft tumors were treated with either a vehicle or ERX-41 (10 mg/kg/day) for a duration of 52 days. Similarly, BALB/c mice with D2A1 xenograft tumors received a treatment of 20 mg/kg/day for 23 days. Following these treatments, histologic architecture in various organs of both the nude mice and BALB/c mice was assessed using H&E staining (a).” This has been corrected in the HTML and PDF versions of the article.